F. Mcgill, R. S. Heyderman, B. D. Michael, S. Defres, N. J. Beeching et al., The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults, J Infect, vol.72, issue.4, pp.405-443, 2016.

, Meningococcal vaccines: polysaccharide and polysaccharide conjugate vaccines, Wkly Epidemiol Rec, vol.77, issue.40, pp.331-340, 2002.

M. Broker, S. Jacobsson, M. Kuusi, D. Pace, M. J. Simoes et al., Meningococcal serogroup Y emergence in Europe: update, Hum Vaccin Immunother, vol.8, issue.12, pp.1907-1918, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-02085551

R. Borrow, J. S. Lee, J. A. Vazquez, G. Enwere, M. K. Taha et al., Meningococcal disease in the Asia-Pacific region: findings and recommendations from the Global Meningococcal Initiative, Vaccine, vol.34, issue.48, pp.5855-62, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-02064090

J. M. Fellick, J. A. Sills, O. Marzouk, C. A. Hart, R. W. Cooke et al., Neurodevelopmental outcome in meningococcal disease: a case-control study, Arch Dis Child, vol.85, issue.1, pp.6-11, 2001.

L. J. Erickson, D. Wals, P. Mcmahon, J. Heim, and S. , Complications of meningococcal disease in college students, Clin Infect Dis, vol.33, issue.5, pp.737-746, 2001.

, Active bacterial core surveillance report, emerging infections program network, Neisseria meningitidis, 2014.

R. Borrow, P. Alarcon, J. Carlos, D. A. Caugant, H. Christensen et al., The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection, Expert Rev Vaccines, pp.1-16, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-02013240

C. Lingani, C. Bergeron-caron, J. M. Stuart, K. Fernandez, M. H. Djingarey et al., Meningococcal meningitis surveillance in the African meningitis belt, Clin Infect Dis, vol.61, issue.5, pp.410-415, 2004.

, Weekly feedback bulletin on cerebrospinal meningitis: West Africa, weeks 48-52. WHO web site, 2016.

D. M. Granoff, I. Feavers, R. Borrow, and . Meningococcal, , pp.959-87, 2003.

. Public-health-england, Meningococcal: meningococcal meningitis and septicaemia notifiable, pp.1-24, 2016.

S. R. Parikh, N. J. Andrews, K. Beebeejaun, H. Campbell, S. Ribeiro et al., Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study, Lancet, vol.388, pp.2775-82, 2016.

M. Ceyhan, S. Anis, L. Htun-myint, R. Pawinski, M. Sorianogabarro et al., Meningococcal disease in the Middle East and North Africa: an important public health consideration that requires further attention, Int J Infect Dis, vol.16, issue.8, pp.574-82, 2012.

A. Razki, E. Hong, K. Zerrouli, B. Ezzaki, I. Diawara et al., In: Presented at: 36 eme Réunion Interdisciplinaire de Chimiothérapie Anti Infectieuse, 2016.

, Situation epidemiologique de l'annee 2012, Relev Epidémiol Mens, vol.23, pp.1-22, 2012.

, Immunization standards e MenAfriVac: Meningococcal A conjugate 10 dose presentation. WHO web site

/. Menaconjugate_10dose_sii/en, , 2016.

M. Ceyhan, N. Gurler, Y. Ozsurekci, M. Keser, A. E. Aycan et al., Meningitis caused by Neisseria meningitidis, Hemophilus influenzae type B and Streptococcus pneumoniae during 2005-2012 in Turkey. A multicenter prospective surveillance study, Hum Vaccin Immunother, vol.10, issue.9, pp.2706-2718, 2014.

M. Ceyhan, I. Yildirim, P. Balmer, R. Borrow, B. Dikici et al., A prospective study of etiology of childhood acute bacterial meningitis, Turkey. Emerg Infect Dis, vol.14, issue.7, pp.1089-96, 2008.

Z. Kurugol, Meningococcal disease and control measures, Turk Klin J Pediatr, vol.15, issue.3, p.98, 2006.

B. Tuysuz, I. Ozlu, and A. Erginal, Epidemiology of meningococcal diseases: a study of 140 patients, Ist Cocuk Klin Derg, vol.27, pp.32-37, 1992.

M. Ceyhan, Y. Ozsurekci, N. Gurler, O. E. Karadag, Y. Camcioglu et al., Bacterial agents causing meningitis during 2013-2014 in Turkey: a multi-center hospital-based prospective surveillance study, Hum Vaccin Immunother, vol.12, issue.11, pp.2940-2945, 2016.

M. Ceyhan, I. Yildirim, P. Balmer, C. Riley, G. Laher et al., Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005, Vaccine, vol.25, issue.41, pp.7233-7240, 2007.

R. Tekin, E. Dinleyici, M. Ceyhan, A. Karbuz, N. Salman et al., The prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkey, pp.1-8, 2017.

E. C. Dinleyici and M. Ceyhan, The dynamic and changing epidemiology of meningococcal disease at the country-based level: the experience in Turkey, Expert Rev Vaccines, vol.11, issue.5, pp.515-523, 2012.

. Department, S. Health, and . Africa, Guidelines for the management, prevention and control of meningococcal disease in South Africa. Department of Health, South Africa, 2011.

G. B. Coulson, M. Du-plessis, A. M. Smith, L. De-gouveia, K. P. Klugman et al., Meningococcal disease in South Africa, Emerg Infect Dis, vol.13, issue.2, pp.273-81, 2007.

A. Von-gottberg, M. Du-plessis, C. Cohen, E. Prentice, S. Schrag et al., Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa, Clin Infect Dis, vol.46, issue.3, pp.377-86, 2008.

S. Meiring, C. Cohen, S. Lengana, C. Von-mollendorf, L. De-gouveia et al., Invasive meningococcal serogroup C and W disease in South Africa: 2003-2014. Poster E25. In: Presented at: Meningitis Research Foundation (MRF) Conference. Meningitis and septicaemia in children and adults, 2015.

C. Cohen, E. Singh, H. M. Wu, S. Martin, L. De-gouveia et al., Increased incidence of meningococcal disease in HIVinfected individuals associated with higher case-fatality ratios in South Africa, AIDS, vol.24, issue.9, pp.1351-60, 2010.

, Surveillance for vaccine preventable diseases (VPDs). WHO web site, 2016.

M. K. Hassan-king, R. A. Wall, and B. M. Greenwood, Meningococcal carriage, meningococcal disease and vaccination, J Infect, vol.16, issue.1, pp.55-64, 1988.
DOI : 10.1016/s0163-4453(88)96117-8

M. C. Maiden and J. M. Stuart, Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination, Lancet, vol.359, issue.9320, pp.1829-1860, 2002.

P. A. Kristiansen, F. Diomande, A. K. Ba, I. Sanou, A. S. Ouedraogo et al., Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity, Clin Infect Dis, vol.56, issue.3, pp.354-63, 2013.

D. M. Daugla, J. P. Gami, K. Gamougam, N. Naibei, L. Mbainadji et al., Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study

, Lancet, vol.383, issue.9911, pp.40-47, 2014.

H. Christensen, M. May, L. Bowen, M. Hickman, and C. L. Trotter, Meningococcal carriage by age: a systematic review and meta-analysis, Lancet Infect Dis, vol.10, issue.12, pp.853-61, 2010.

C. L. Trotter and B. M. Greenwood, Meningococcal carriage in the African meningitis belt, Lancet Infect Dis, vol.7, issue.12, pp.797-803, 2007.

A. Karachaliou, A. Conlan, M. P. Preziosi, and C. L. Trotter, Modeling long-term vaccination strategies with MenAfriVac in the African meningitis belt, Clin Infect Dis, vol.61, issue.5, pp.594-600, 2015.

S. N. Ladhani, K. Beebeejaun, J. Lucidarme, H. Campbell, S. Gray et al., Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales, Clin Infect Dis, vol.60, issue.4, pp.578-85, 2015.

R. Abad and J. A. Vazquez, Early evidence of expanding W ST-11 CC meningococcal incidence in Spain, J Infect, vol.73, issue.3, pp.296-303, 2016.

J. Lucidarme, D. Hill, H. B. Bratcher, S. J. Gray, M. Du-plessis et al., Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage, J Infect, vol.71, issue.5, pp.232-239, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-02013265

J. Gaschignard, C. Levy, A. E. Deghmane, F. Dubos, M. Muszlak et al., Invasive serogroup W meningococcal disease in children: a national survey from 2001 to 2008 in France. Pediatr, Infect Dis J, vol.32, issue.7, pp.798-800, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02095661

H. Campbell, S. R. Parikh, R. Borrow, E. Kaczmarski, M. E. Ramsay et al., Presentation with gastrointestinal symptoms and high case fatality associated with group W meningococcal disease (MenW) in teenagers, Euro Surveill, vol.21, issue.12, 2015.

M. K. Taha, M. Achtman, J. M. Alonso, B. Greenwood, M. Ramsay et al., Serogroup W135 meningococcal disease in Hajj pilgrims, Lancet, vol.356, issue.9248, p.2159, 2000.

Y. Al-mazrou, M. Khalil, R. Borrow, P. Balmer, J. Bramwell et al., Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age, Infect Immun, vol.73, issue.5, pp.2932-2941, 2005.

. Departamento-de-epidemiología, Informe vigilancia de enfermedad meningoc ocica, Departamento de Epidemiología. Available, 2017.

. Departamento-de-epidemiología, Enfermedad meningoc ocica (CIE10:A39) situaci on epidemiol ogica, Enero-Diciembre. Departamento de Epidemiología, 2015.

S. N. Ladhani, M. Ramsay, R. Borrow, A. Riordan, J. M. Watson et al., Enter B and W: two new meningococcal vaccine programmes launched, Arch Dis Child, vol.101, issue.1, pp.91-96, 2016.

H. Christensen, C. L. Trotter, M. Hickman, and W. J. Edmunds, Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study, BMJ, vol.349, p.5725, 2014.

H. Christensen and C. L. Trotter, Modelling the cost-effectiveness of catch-up 'MenB' (Bexsero) vaccination in England, Vaccine, vol.35, issue.2, pp.208-219, 2017.

C. L. Trotter and W. J. Edmunds, Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model, Med Decis Mak, vol.26, issue.1, pp.38-47, 2006.

, World Health Organization. WHO position paper on meningococcal A conjugate vaccine. WHO web site, p.22

S. Zipursky, M. H. Djingarey, J. C. Lodjo, L. Olodo, S. Tiendrebeogo et al., Benefits of using vaccines out of the cold chain: delivering meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin, vol.32, pp.1431-1436, 2014.

R. Borrow, Y. Tang, A. Yakubu, P. S. Kulkarni, and F. M. Laforce, MenAfriVac as an antitetanus vaccine, Clin Infect Dis, vol.61, issue.5, pp.570-577, 2015.
DOI : 10.1093/cid/civ512

URL : https://academic.oup.com/cid/article-pdf/61/suppl_5/S570/20914090/civ512.pdf

J. R. Macneil, I. Medah, D. Koussoube, R. T. Novak, A. C. Cohn et al., Neisseria meningitidis serogroup W, Burkina Faso, Emerg Infect Dis, vol.20, issue.3, pp.394-403, 2012.

J. Chow, K. Uadiale, A. Bestman, C. Kamau, D. A. Caugant et al., Invasive meningococcal meningitis serogroup C outbreak in northwest Nigeria, 2015-third consecutive outbreak of a new strain, PLoS Curr, vol.8, 2016.

C. B. Kretz, A. C. Retchless, F. Sidikou, B. Issaka, S. Ousmane et al., Whole-genome characterization of epidemic Neisseria meningitidis serogroup C and resurgence of serogroup W, Emerg Infect Dis, vol.22, issue.10, pp.1762-1770, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-02056224

A. Funk, K. Uadiale, C. Kamau, D. A. Caugant, U. Ango et al., Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, PLoS Curr, vol.6, pp.2013-2027, 2014.

, Product pipeline. Serum Institute of India, p.25, 2017.

J. R. Macneil, L. G. Rubin, M. Patton, I. R. Ortega-sanchez, and S. W. Martin, Recommendations for use of meningococcal conjugate vaccines in HIV-infected persons-advisory Committee on Immunization Practices, MMWR Morb Mortal Wkly Rep, vol.65, issue.43, pp.1189-94, 2016.

W. Kipp, J. Kamugisha, and T. Rehle, Meningococcal meningitis and HIV infection: results from a case-control study in western Uganda, AIDS, vol.6, issue.12, pp.1557-1565, 1992.
DOI : 10.1097/00002030-199212000-00031

N. Morla, M. Guibourdenche, and J. Y. Riou, Neisseria spp. and AIDS, J Clin Microbiol, vol.30, issue.9, 1992.

D. L. Couldwell, Invasive meningococcal disease and HIV coinfection, Commun Dis Intell Q Rep, vol.25, issue.4, p.279, 2001.

D. S. Stephens, R. A. Hajjeh, W. S. Baughman, R. C. Harvey, J. D. Wenger et al., Sporadic meningococcal disease in adults: results of a 5-year population-based study, Ann Intern Med, vol.123, issue.12, pp.937-977, 1995.

L. Miller, L. Arakaki, A. Ramautar, S. Bodach, S. L. Braunstein et al., Elevated risk for invasive meningococcal disease among persons with HIV, Ann Intern Med, vol.160, issue.1, pp.30-37, 2014.
DOI : 10.7326/0003-4819-160-1-201401070-00731

G. K. Siberry, M. G. Warshaw, P. L. Williams, S. A. Spector, M. D. Decker et al., Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2-to 10-year-old human immunodeficiency virus-infected children, Pediatr Infect Dis J, vol.31, issue.1, pp.47-52, 2012.

G. K. Siberry, P. L. Williams, J. Lujan-zilbermann, M. G. Warshaw, S. A. Spector et al., Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents, Pediatr Infect Dis J, vol.29, issue.5, pp.391-397, 2010.

H. British and . Association, British HIV Association guidelines on the use of vaccines in HIV-positive adults. British HIV Association, p.23, 2015.

M. K. Taha, H. Claus, M. Lappann, F. J. Veyrier, A. Otto et al., Evolutionary events associated with an outbreak of meningococcal disease in men who have sex with men, PLoS One, vol.11, issue.5, p.154047, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01351740

, Advocacy for Immunization. Welcome to advocacy for immunisation. Advocacy for Immunization, 2016.

, Meningis Now web site, 2016.